Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Epidemiol Health. 2020;42:e2020075. doi: 10.4178/epih.e2020075. Epub 2020 Dec 16.
Cervical cancer is a major disease burden in Vietnam. This study aimed to estimate the incidence and mortality rates of cervical cancer in Vietnam (1999-2017) in comparison to those in Korea, where a population-based cancer registry and national cervical cancer screening program have been implemented.
The estimated incidence and mortality of cervical cancer in Vietnam and Korea (1999-2017) were collected from Global Burden of Disease 2017 study. Estimated age-standardized rates (ASRs) in both countries were calculated utilizing the 1999-2017 population of each country and the World Health Organization standard population. The reported ASRs in Korea were also computed using data on incidence and mortality (1999-2017) and the Korean population from the Korea Statistical Information Service.
In Vietnam, the estimated incidence and mortality of cervical cancer decreased annually by 0.84% and 1.01%. In Korea, the trend of reported incidence showed a dramatic drop (1999-2007 annual percent change [APC], -4.53%) before stably declining (2007-2017 APC, -2.71%). Reported mortality also significantly decreased (2003-2008 APC, -6.63%), and then maintained a stable decline (2008-2017 APC, -3.78%). The incidence and mortality rates were higher in Vietnam than in Korea. The declining trend of incidence and mortality in Vietnam was slower than the corresponding trends in Korea.
A national screening program should be implemented for Vietnamese women aged over 30 to maintain, or even hasten, the decline in cervical cancer incidence and mortality. A population-based cancer registry may help monitor the effectiveness of a cervical cancer screening program.
宫颈癌是越南的一个主要疾病负担。本研究旨在与韩国相比,估计越南(1999-2017 年)宫颈癌的发病率和死亡率,韩国已实施基于人群的癌症登记处和国家宫颈癌筛查计划。
从 2017 年全球疾病负担研究中收集了越南和韩国(1999-2017 年)的宫颈癌发病率和死亡率估计值。利用两国 1999-2017 年的人口和世界卫生组织标准人口计算了两国的估计年龄标准化率(ASR)。还利用韩国发病率和死亡率(1999-2017 年)以及韩国统计信息服务处的韩国人口数据计算了报告的韩国 ASR。
在越南,宫颈癌的发病率和死亡率每年分别下降 0.84%和 1.01%。在韩国,报告的发病率趋势显示出急剧下降(1999-2007 年的年变化百分比[APC],-4.53%),然后稳定下降(2007-2017 年的 APC,-2.71%)。报告的死亡率也显著下降(2003-2008 年的 APC,-6.63%),然后保持稳定下降(2008-2017 年的 APC,-3.78%)。越南的发病率和死亡率高于韩国。越南发病率和死亡率的下降趋势比韩国相应的趋势缓慢。
应在 30 岁以上的越南妇女中实施国家筛查计划,以维持甚至加快宫颈癌发病率和死亡率的下降。基于人群的癌症登记处可以帮助监测宫颈癌筛查计划的有效性。